PMC:7247521 / 27354-27533
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 413 | 127-133 | CellLine | denotes | Caco-2 | CVCL:0025 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T342 | 44-53 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T343 | 87-91 | UBERON:0000165 | denotes | oral |
| T344 | 127-133 | CL_1 | denotes | Caco-2 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T85 | 134-138 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T86 | 161-165 | Body_part | denotes | skin | http://purl.org/sig/ont/fma/fma7163 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T24 | 161-165 | Body_part | denotes | skin | http://purl.obolibrary.org/obo/UBERON_0000014 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T215 | 75-76 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T216 | 127-138 | http://purl.obolibrary.org/obo/CLO_0002172 | denotes | Caco-2 cell |
| T217 | 161-165 | http://purl.obolibrary.org/obo/UBERON_0000014 | denotes | skin |
| T218 | 161-165 | http://purl.obolibrary.org/obo/UBERON_0001003 | denotes | skin |
| T219 | 161-165 | http://purl.obolibrary.org/obo/UBERON_0002097 | denotes | skin |
| T220 | 161-165 | http://purl.obolibrary.org/obo/UBERON_0002199 | denotes | skin |
| T221 | 161-165 | http://www.ebi.ac.uk/efo/EFO_0000962 | denotes | skin |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T196 | 0-179 | Sentence | denotes | Regarding the absorption parameters, all 20 compounds (Table 2 ) presented a promising oral availability including the optimal Caco-2 cell permeability, HIA and skin permeability. |